Formula & Concentration
CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use
CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Shelf Life and Storage
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Do not freeze.
Unopened vials may be stored in the original carton at room temperature up to 30°C (86°F) for a single period of up to 2 months.
Do not return CABLIVI to the refrigerator after it has been stored at room temperature.